# ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD

> **NCT00190437** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 520 (actual)

## Conditions studied

- Chronic Obstructive Lung Disease (COLD)

## Interventions

- **DRUG:** Amoxicillin-clavulanic

## Key facts

- **NCT ID:** NCT00190437
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2011-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190437, "ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00190437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*